MARKET

GENE

GENE

Genetic
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.840
+0.040
+2.22%
Closed 16:00 11/14 EST
OPEN
1.850
PREV CLOSE
1.800
HIGH
1.876
LOW
1.800
VOLUME
16.48K
TURNOVER
--
52 WEEK HIGH
6.32
52 WEEK LOW
1.560
MARKET CAP
2.03M
P/E (TTM)
-0.4585
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of GENE and other stocks commission-free!

Open a Webull account and fund it to get a free stock

EPS

GENE News

  • Genetic Technologies Offers Shareholder Update On Recent Achievements, Upcoming Milestones
  • Benzinga.11/05 12:57
  • Genetic Technologies Provides Shareholder Update on Recent Achievements and Upcoming Milestones
  • GlobeNewswire.11/05 12:00
  • Genetic Technologies Reports issue of 928,397,236 Ordinary Shares in the Company on October 28 2019
  • Benzinga.10/31 08:26
  • Genetic Technologies Says Now in a Position to Comply With Its Nasdaq Listing
  • Benzinga.10/29 07:44

More

Industry

Healthcare Facilities & Services
+0.21%
Healthcare Providers & Services
+0.22%

Hot Stocks

Name
Price
%Change

About GENE

Genetic Technologies Limited is a molecular diagnostics company. The Company is engaged in the provision of molecular risk assessment for cancer. The Company offers predictive testing and assessment tools for physicians to manage women's health. The Company's lead product, BREVAGenplus, is a clinically validated risk assessment test for non-hereditary breast cancer. The Company markets BREVAGenplus to healthcare professionals in breast healthcare and imaging centers, as well as to obstetricians/gynecologists (OBGYNs) and breast cancer risk assessment specialists, such as breast surgeons. The Company operates in Australia, the United States and Switzerland. The Company's subsidiaries include Genetic Technologies Corporation Pty. Ltd. and Phenogen Sciences Inc. Genetic Technologies Corporation Pty. Ltd. is engaged in genetic testing. The Company has launched the BREVAGen test across the United States through Phenogen Sciences Inc.
More

Webull offers Genetic Technologies Limited (ADR) (GENE) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.